Veterinary Biologics Market Size and Growth Forecast for Businesses 2025–2029

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Veterinary Biologics Market Size During 2025–2029?

The veterinary biologics market has experienced substantial expansion in recent years. This market is anticipated to expand from $12.67 billion in 2024 to $13.61 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. Historically, this growth has been fueled by factors such as animal disease outbreaks, strong regulatory support and standards, rising demand for food safety, the globalization of trade, and the economic significance of livestock.

The veterinary biologics market is projected to experience significant expansion in the coming years, reaching a size of $18.36 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is attributed to factors like emerging infectious diseases, climate change and evolving disease patterns, precision livestock farming, the one health approach, and increasing pet ownership trends. Prominent developments expected in this period include education and training programs, the introduction of eco-friendly and sustainable biologics, the integration of digital health records, an increase in companion animal biologics, and the development of customized and targeted therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Which Drivers Are Shaping The Veterinary Biologics Industry’s Market Share?

The increasing occurrence of animal illnesses is anticipated to boost the expansion of the veterinary biologics market. These diseases encompass various health problems and conditions impacting diverse animal species. A rise in animal diseases fuels the demand for improved diagnostic tools and therapeutic solutions, which veterinary biologics, utilizing immunological approaches, effectively provide. For example, data from October 2022, reported by the European Center for Disease Prevention and Control, an EU health agency based in Sweden, documented 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, alongside 187 instances observed in captive birds. Additionally, as per the World Health Organization, a specialized UN agency located in Switzerland, 59,000 individuals succumb to rabies each year across more than 150 countries, with 95% of these fatalities concentrated in Africa and Asia, as of July 2022. Consequently, the growing incidence of animal diseases is propelling the use of veterinary biologics.

What Are The Emerging Segments Gaining Attention In The Veterinary Biologics Market?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

What Trends Are Expected To Drive The Veterinary Biologics Market?

Companies operating in the veterinary biologics market are increasingly focusing on developing innovative biologics, particularly vaccines, to improve animal health and prevent diseases. A vaccine functions by stimulating the immune system to recognize and fight specific pathogens, thereby preventing infectious diseases through the provision of acquired immunity. For example, in August 2024, Merck Animal Health, a US-based global animal health company, introduced an experimental autogenous vaccine specifically targeting avian metapneumovirus (aMPV) type B, following approval for its manufacturing and sale from the U.S. Department of Agriculture (USDA). This vaccine, developed in collaboration with Cambridge Technologies, is intended to counteract the severe respiratory problems in poultry caused by aMPV type B, which have led to significant economic losses since late 2023. Manufactured at a modern facility in Minnesota, the vaccine utilizes an oil and water emulsion formulation designed to minimize tissue reactions post-vaccination, thereby addressing a critical unmet need in the market as no commercially licensed vaccines were previously accessible.

Who Are The Primary Competitors In The Global Veterinary Biologics Market?

Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Veterinary Biologics Market?

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Veterinary Biologics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Browse Through More Reports Similar to the Global Veterinary Biologics Market 2025, By The Business Research Company

Veterinary Anesthesia Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

Veterinary Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795